Search
SOLACI Congress
HomeFilePeripheral vascular disease

Peripheral vascular disease

View Category

Antithrombotic Anticoagulants

TCT 2025 | STORM-PE: Mechanical Thrombectomy with Penumbra Lightning+AC vs. Anticoagulation Alone in Intermediate-High Risk PE

Intermediate-high risk pulmonary embolism (PE) remains a therapeutic challenge. Anticoagulation is still the standard treatment, albeit with...
Dr. Omar Tupayachi -
Learn More
Coronary disease

Treatment of Femoropopliteal Lesions with Drug-Coated Balloons: IVUS vs. Conventional Angiography

Angiography has traditionally been the standard imaging technique to guide endovascular therapy (EVT) in patients with peripheral...
Dr. Andrés Rodríguez -
Learn More
Peripheral vascular disease

ESC 2025 | SWEDEPAD 1 and 2: Paclitaxel-Coated Devices in Peripheral Artery Disease

In patients with peripheral artery disease, “improving” prognosis means relieving walking pain, increasing walking distance, preventing amputations,...
Dr. Juan Manuel Pérez -
Learn More
Peripheral vascular disease

Evolution of Renal Denervation at 24 Months

Arterial hypertension is a modifiable risk factor for cardiovascular events. In many cases, however, patients struggle to...
Dr. Carlos Fava -
Learn More
Aorta

Statins and Small Abdominal Aortic Aneurysms: Unexpected Aid?

Courtesy of Dr. Juan Manuel Pérez. Abdominal aortic aneurysms (AAA) entail high morbimortality in case of rupture, and...
Dr. Juan Manuel Pérez -
Learn More
Peripheral vascular disease

Renal Denervation and SPYRAL HTN-ON MED Two-Year Outcomes

High blood pressure (BP) continues to be one of the leading preventable causes of cardiovascular events worldwide....
Dr. Omar Tupayachi -
Learn More
Femoropopliteal

Post-Rotational Atherectomy Imaging in Femoropopliteal Lesions (INSIGHT-JETSTREAM)

Severely calcified femoropopliteal disease represents a significant clinical challenge, particularly concerning adequate lesion preparation before the implantation...
Dr. Omar Tupayachi -
Learn More
Peripheral vascular disease

Renal Denervation, 24-Month Evolution

Hypertension is a very common condition, and generally manageable. However, as we know, it is associated to...
Dr. Carlos Fava -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Dr. Andrés Rodríguez - 0
Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Institutional News

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

solaci - 0
Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy